Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 06, 2016 ) This Pharmaceutical Industry report shows that the Pharmaceutical companies use deal activity to enhance their research activities, regulatory approach, geographic presence, commercialization, and sales. The increasing development of biologics, especially in oncology, has given a significant boost to activity in recent years. Analysis suggests that while the number of deals in 2015 (until July) was lower than the number of deals in 2014, deal value in 2015 has already exceeded that of 2014.
Looking at the entire period, although strategic deals were more numerous, M&A deals had the highest deal value. Partnerships were the most preferred type of deal activity, but saw the lowest deal value. North America led in terms of region, followed by Europe and Asia-Pacific. Key deals covered in this report include the acquisition of Allergen by Actavis, asset transactions between Novartis and GlaxoSmithKline, and the partnership between Pfizer and Merck.
Other Key Points in Report:
- Which challenges in the pharmaceutical industry are encouraging deal activity? - How important is deal activity to the market? Overview of deal activity from 2010 to 2015 - - What are the trends for M&A and strategic deals, and what are the key differences between the sectors? - What was the trend for regional involvement in each year? - How do variations in terms of therapy area preference affect deal activity? Detailed analysis of recent deal activity - - How do announced and completed deals vary? - How do deals in 2014 and 2015 compare in terms of quarterly volume and value? - Which regions or therapy areas have encouraged recent deal activity? - Who are the key players? Complete analysis of recent M&A deals - - How do M&A deal types differ in terms of number and value? - Which regions and therapy areas have been involved in M&A deals since 2013? - Who are the most important players in M&A deals? - What was the rationale behind key M&A deals?
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001170007/buying
Reasons to Buy
This report will allow you to - - Gain an insight into pharmaceutical deal activity via in-depth analysis of the current pharmaceutical industry, along with a focus on the most lucrative regions and therapy areas for both M&A and strategic deals - Examine detailed analysis of key players, covering companies involved in M&A and strategic alliance deals, important deal activity for all deal types, and deals involving companies with the most numerous and highest-value deals. - Understand how the current deals market is changing, using analysis of deals by molecule type, route of administration, and stage of development. - Determine the most appropriate deal activity for overcoming challenges and enhancing performance, including detailed analysis of the rationale behind key recent deals.
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001170007/sample
Table of Content: An Overview
Executive summary Introduction Overview Traditional Model vs. Evolving Model Factors Promoting Deal Activity One-Stop Solution to Current Pharmaceutical Challenges Deal Types Overview of Pharmaceutical Deals from 2010 to 2015 Number of Pharmaceutical Deals and Value by Year Pharmaceutical Deals by Region Pharmaceutical Deals by Therapy Area Overall Deal Analysis for 2014 and 2015 Announced and Completed Deals Number of Deals and Deal Value by Deal Type Number of Deals and Deal Value by Quarter Regions of Deal Occurrence Therapy Areas Promoting Deal Activity
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001170007/discount
Key Players in Deal Activity by Number of Deals and Deal Value Mergers and Acquisitions Deal Activity for 2014 and 2015 Mergers and Acquisitions by Type of Deal and Deal Value Mergers and Acquisitions by Region Mergers and Acquisitions by Therapy area Key Players in Mergers and Acquisitions Description of Key Deals by Value Strategic Alliances Deal Activity for 2014 and 2015 Strategic Alliance Deals by Type of Deal and Deal Value Strategic Alliance Deals by Aggregate Deal Value, Upfront Payment and Milestone Payment Strategic Alliance Deals by Region Strategic Alliance Deals by Therapy Area Strategic Alliance Deals by Product Phase Strategic Alliance Deals by Molecule Type Strategic Alliance Deals by Route of Administration Key Players in Strategic Alliances Description of Key Deals by Value
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001170007/buy/2995
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|